Is antibiotic prophylaxis effective in preventing urinary tract infections in patients with vesicoureteral reflux?

Expert Review of Anti-Infective Therapy

Volumn 8, Issue 1, 2010, Pages 51-58

  Hayashi, Yutaro ^a   Kojima, Yoshiyuki ^a   Kamisawa, Hideyuki ^a   Imura, Makoto ^a   Mizuno, Kentaro ^a   Kohri, Kenjiro ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

antibiotic prophylaxis; pediatrics; vesicoureteral reflux

Indexed keywords

COTRIMOXAZOLE; NITROFURANTOIN; PLACEBO; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; CYSTITIS; DISEASE SEVERITY; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; KIDNEY FAILURE; PATIENT ASSESSMENT; PYELONEPHRITIS; REMISSION; REVIEW; RISK ASSESSMENT; SKIN MANIFESTATION; TREATMENT DURATION; TREATMENT OUTCOME; URETER SURGERY; URINARY TRACT INFECTION; VESICOURETERAL REFLUX; INCIDENCE; INFANT; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CHILD, PRESCHOOL; HUMANS; INCIDENCE; INFANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; URINARY TRACT INFECTIONS; VESICO-URETERAL REFLUX;

EID: 77954480400     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.09.111     Document Type: Review

References (59)

1. Smellie JM, Katz G, Gruneberg RN. Controlled trial of prophylactic treatment in childhood urinary-tract infection. Lancet 2, 175-178 (1978). (Pubitemid 8385015)
2. Lohr JA, Nunley DH, Howards SS, Ford RF. Prevention of recurrent urinary tract infections in girls. Pediatrics 59, 562-565 (1977). (Pubitemid 8092809)
3. Hutch JA, Bunge RG, Flocks RH. Vesicoureteral refux in children. J. Urol. 74, 607-620 (1955).
4. Pasquier CM Jr, St Martin EC, Campbell JH. The problem of vesicoureteral refux in children. J. Urol. 79, 41-51 (1958).
5. Kendall AR, Karafn L. Urinary tract infection in children: fact and fantasy. J. Urol. 107, 1068-1072 (1972).
6. Smellie JM, Hodson CJ, Edwards D, Normand ICS. Clinical and radiological features of urinary infection in childhood. Br. Med. J. 2, 1222-1226 (1964).
7. Elder JS, Peters CA, Arant BS Jr et al. Pediatric vesicoureteral refux guidelines panel summary report on the management of primary vesicoureteral refux in children. J. Urol. 157, 1846-1851 (1997). (Pubitemid 27171791)
8. Lenaghan D. Results of conservative treatment of vesicoureteric refux in children. Br. J. Urol. 42, 736 (1970)
9. International Refux Study Committee. Medical versus surgical treatment of primary vesicoureteral refux: a prospective international refux study in children. J. Urol. 125, 277-283 (1981).
10. Govan DE, Fair WR, Friedland GW, Filly RA. Urinary tract infections in children. Part III-treatment of ureterovesical refux. West. J. Med. 121, 382-389 (1974).
11. O'Donnell B, Moloney MA, Lynch V. Vesico-ureteric refux in infants and children: results of 'supervision', chemotherapy and surgery. Br. J. Urol. 41, 6-12 (1969).
12. Goldraich NP, Goldraich IH. Follow up of conservatively treated children with high and low grade vesicoureteral refux: a prospective study. J. Urol. 148, 1688-1692 (1992).
13. Arant BS Jr. Medical management of mild and moderate vesicoureteral refux: follow up studies of infants and young children. A preliminary report of the Southwest Pediatric Nephrology Study Group. J. Urol. 148, 1683-1687 (1992).
14. Skoog SJ, Belman AB, Majd M. A non-surgical approach to the management of primary vesicoureteral refux. J. Urol. 138, 941-946 (1987). (Pubitemid 17150799)
15. Edwards D, Normand ICS, Prescod N, Smellie JM. Disappearance of vesicoureteric refux during long-term prophylaxis of urinary tract infection in children. Br. Med. J. 2, 285-288 (1977). (Pubitemid 8153937)
16. Bellinger MF, Duckett JW. Vesicoureteral refux: a comparison of non-surgical and surgical management. Contrib. Nephrol. 39, 81-93 (1984).
17. Tamminen-Mobius T, Brunier E, Ebel KD et al. Cessation of vesicoureteral refux for 5 years in infants and children allocated to medical treatment. The International Refux Study in Children. J. Urol. 148, 1662-1666 (1992).
18. Yeung CK, Godley ML, Dhillon HK, Gordon I, Duffy PG, Ransley PG. The characteristics of primary vesico-ureteric refux in male and female infants with pre-natal hydronephrosis. Br. J. Urol. 80, 319-327 (1997). (Pubitemid 28318903)
19. Sjöström S, Sillén U, Bachelard M, Hansson S, Stokland E. Spontaneous resolution of high grade infantile vesicoureteral refux. J. Urol. 172, 694-699 (2004).
20. Jerkins GR, Noe HN. Familial vesicoureteral refux: a prospective study. J. Urol. 128, 774-778 (1982). (Pubitemid 13236356)
21. Schwab CW Jr, Wu HY, Selman H, Smith GHH, Snyder HM, Canning DA. Spontaneous resolution of vesicoureteral refux: a 15-year perspective. J. Urol. 168, 2594-2599 (2002). (Pubitemid 35402698)
22. Zerin JM, Ritchey ML, Chang AC. Incidental vesicoureteral refux in neonates with antenatally detected hydronephrosis and other renal abnormalities. Radiology 187, 157-160 (1993). (Pubitemid 23097878)
23. Gordon AC, Thomas DF, Arthur RJ, Irving HC, Smith SE. Prenatally diagnosed refux: a follow-up study. Br. J. Urol. 65, 407-412 (1990). (Pubitemid 20150069)
24. Steele BT, Robitaille P, DeMaria J, Grignon A. Follow-up evaluation of prenatally recognized vesicoureteric refux. J. Pediatr. 115, 95-96 (1989). (Pubitemid 19177974)
25. Kaplan WE, Nasrallah P, King LR. Refux in complete duplication in children. J. Urol. 120, 220-222 (1978).
26. Peppas DS, Skoog SJ, Canning DA, Belman AB. Nonsurgical management of primary vesicoureteral refux in complete ureteral duplication: is it justifed? J. Urol 146, 1594-1595 (1991).
27. Fehrenbaker LG, Kelalis PP, Stickler GB. Vesicoureteral refux and ureteral duplication in children. J. Urol. 107, 862-864 (1972).
28. Estrada CR Jr, Passerotti CC, Graham DA et al. Nomograms for predicting annual resolution rate of primary vesicoureteral refux: refux from 2,462 children. J. Urol 182, 1535-1541 (2009).
29. Hodson EM, Wheeler DM, Vimalchandra D, Smith GH, Craig JC. Interventions for primary vesicoureteric refux. Cochrane Database Syst. Rev. 3, CD001532 (2007).
30. Capozza N, Caione P. Dextranomer/hyaluronic acid copolymer implantation for vesico-ureteral refux: a randomized comparison with antibiotic prophylaxis. J. Pediatr. 140, 230-234 (2002). (Pubitemid 34183664)
31. Piepsz A, Tamminen-Möbius T, Reiners C et al. Five-year study of medical or surgical treatment in children with severe vesico-ureteral refux dimercaptosuccinic acid fndings. Eur. J. Pediatr. 157, 753-758 (1998) (Pubitemid 28419105)
32. Birmingham Refux Study Group. Prospective trial of operative versus non-operative treatment of severe vesicoureteric refux in children: five years' observation. Br. Med. J. 295, 237-241 (1987).
33. Jodal U, Smellie JM, Lax H, Hoyer PF. Ten-year results of randomized treatment of children with severe vesicoureteral refux. Final report of the International Refux Study in Children. Pediatr. Nephrol. 21, 785-792 (2006). (Pubitemid 43740945)
34. Williams G, Lee A, Craig J. Antibiotics for the prevention of urinary tract infection in children: a systematic review of randomized controlled trials. J. Pediatr. 138, 868-874 (2001). (Pubitemid 32545589)
35. Wald ER. Vesicoureteral refux: the role of antibiotic prophylaxis. Pediatrics 117, 919-922 (2006). (Pubitemid 46063235)
36. Uhari M, Nuutinen M, Turtinen J. Adverse reaction in children during long-term antimicrobial therapy. Pediatr. Infect. Dis. J. 15, 404-408 (1996). (Pubitemid 26151209)
37. Karpman E, Kurzrock EA. Adverse reactions of nitrofurantonin, trimethoprim and sulfamethoxazole in children. J. Urol. 172, 448-453 (2004). (Pubitemid 38900174)
38. Conway PH, Cnaan A, Zaoutis T, Henry BV, Grundmeier RW, Keren R. Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA 298, 179-186 (2007). (Pubitemid 47057764)
39. Lutter SA, Currie ML, Mitz LB, Greenbaum LA. Antibiotic resistance patterns in children hospitalized for urinary tract infections. Arch. Pediatr. Adolesc. Med. 159, 924-928 (2005). (Pubitemid 41423330)
40. Hensle TW, Hyun G, Grogg AL, Eaddy M. Examining pediatric vesicoureteral refux: a real-world evaluation of treatment patterns and outcomes. Curr. Med. Res. Opin. 23(Suppl.), 7-13 (2007).
41. Pylkkanen J, Vilska J, Koskimies O. The value of level diagnosis of childhood urinary tract infection in predicting renal injury. Acta. Paediatr. Scand. 70, 879-883 (1981). (Pubitemid 11027052)
42. Naseer SR, Steinhardt GF. New renal scars in children with urinary tract infections, vesicoureteral refux and voiding dysfunction: a prospective evaluation. J. Urol. 158, 566-568 (1997). (Pubitemid 27327717)
43. Cooper CS, Chung BI, Kirsch AJ, Canning DA, Snyder HM. The outcome of stopping prophylactic antibiotics in older children with vesicoureteral refux. J. Urol. 163, 269-273 (2000).
44. Thompson RH, Chen JJ, Pugach J, Naseer S, Steinhardt GF. Cessation of prophylactic antibiotics for managing persistent vesicoureteral refux. J. Urol. 166, 1465-1469 (2001). (Pubitemid 32862219)
45. Hellerstein S, Nickell E. Prophylactic antibiotics in children at risk for urinary tract infection. Pediatr. Nephrol. 17, 506-510 (2002). (Pubitemid 36097313)
46. Al-Sayyad AJ, Pike JG, Leonard MP. Can prophylactic antibiotics safely be discontinued in children with vesicoureteral refux? J. Urol. 174, 1587-1589 (2005). (Pubitemid 41318631)
47. Georgaki-Angelaki H, Kostaridou S, Daikos GL et al. Long-term follow-up of children with vesicoureteral refux with and without antibiotic prophylaxis. Scand. J. Infect. Dis. 37, 842-845 (2005).
48. Alconcher LF, Meneguzzi MB, Buschiazzo R, Piaggio LA. Could prophylatic antibiotics be stopped in patients with history of vesicoureteral refux? J. Pediatr. Urol. 5(5), 383-388 (2009).
49. Wheeler DM, Vimalachandra D, Hodson EM, Roy LP, Smith GH, Craig JC. Antibiotics and surgery for vesicoureteric refux: a meta-analysis of randomised controlled trials. Arch. Dis. Child. 88, 688-694 (2003). (Pubitemid 36930305)
50. Mori R, Lakhanpaul M, Verrier-Jones K. Diagnosis and management of urinary tract infection in children: summary of NICE guidance. Br. Med. J. 335, 395-397 (2007). (Pubitemid 47359319)
51. Garin EH, Olavarria F, Nieto VG, Valenciano B, Campos A, Young L. Clinical signifcance of primary vesicoureteral refux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics 117, 626-632 (2006). (Pubitemid 46063202)
52. Pennesi M, Travan L, Peratoner L et al. Is antibiotic prophylaxis in children with vesicoureteral refux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics 121, e1489-e1494 (2008).
53. Roussey-Kesler G, Gadjos V, Idres N et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral refux: results from a prospective randomized study. J. Urol. 179, 674-679 (2008).
54. Montini G, Rigon L, Zucchetta P et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics 122, 1064-1071 (2008).
55. De Cunto A, Pennesi M, Salierno P. Re: antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral refux: results from a prospective randomized study. J. Urol. 180, 2258-2259 (2008).
56. Montini G, Hewitt I. Urinary tract infections: to prophylaxis or not to prophylaxis? Pediatr. Nephrol. 24, 1605-1609 (2009).
57. Chesney RW, Carpenter MA, Moxey-Mims M et al. Randomized intervention for children with vesicoureteral refux (RIVUR): background commentary of RIVUR investigators. Pediatrics 122(Suppl.), s233-s239 (2008).
58. Brandstrom P, Hansson S. Swedish refux study in children. Presented at: 42nd Annual ESPN meeting. Lyon, France, 11-14 September 2008.
59. Craig JC, Irwig LM, Knight JF. Does treatment of vesicoureteric refux in childhood prevent end-stage renal disease attribute to refux nephropathy? Pediatrics 105, 1236-1241 (2000). (Pubitemid 30346892)